During the last session, Prothena Corporation plc (NASDAQ:PRTA)’s traded shares were 0.51 million, with the beta value of the company hitting 0.16. At the end of the trading day, the stock’s price was $16.65, reflecting an intraday loss of -2.06% or -$0.35. The 52-week high for the PRTA share is $41.54, that puts it down -149.49 from that peak though still a striking 8.11% gain since the share price plummeted to a 52-week low of $15.30. The company’s market capitalization is $895.45M, and the average intraday trading volume over the past 10 days was 0.49 million shares, and the average trade volume was 461.52K shares over the past three months.
Prothena Corporation plc (PRTA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. PRTA has a Sell rating from 1 analyst(s) out of 15 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 11 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -1.18.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Prothena Corporation plc (NASDAQ:PRTA) trade information
Prothena Corporation plc (PRTA) registered a -2.06% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -2.06% in intraday trading to $16.65, hitting a weekly high. The stock’s 5-day price performance is 8.82%, and it has moved by -0.89% in 30 days. Based on these gigs, the overall price performance for the year is -54.61%. The short interest in Prothena Corporation plc (NASDAQ:PRTA) is 6.79 million shares and it means that shorts have 10.0 day(s) to cover.
The consensus price target of analysts on Wall Street is $56, which implies an increase of 70.27% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $24 and $98 respectively. As a result, PRTA is trading at a discount of -488.59% off the target high and -44.14% off the low.
Prothena Corporation plc (PRTA) estimates and forecasts
Statistics show that Prothena Corporation plc has underperformed its competitors in share price, compared to the industry in which it operates. Prothena Corporation plc (PRTA) shares have gone down -27.39% during the last six months, with a year-to-date growth rate less than the industry average at 15.22% against 17.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -410.50% this quarter and then jump 17.50% in the quarter after that. In the rating firms’ projections, revenue will increase 57.50% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.23M as predicted by 8 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to 10.59M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 84.87M and 316k respectively. In this case, analysts expect current quarter sales to shrink by -98.60% and then jump by 3,251.30% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 6.83%. While earnings are projected to return 15.73% in 2024, the next five years will return 34.07% per annum.
PRTA Dividends
Prothena Corporation plc is due to release its next quarterly earnings on 2024-Nov-04. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Prothena Corporation plc (NASDAQ:PRTA)’s Major holders
Prothena Corporation plc insiders own 12.42% of total outstanding shares while institutional holders control 95.85%, with the float percentage being 109.45%. ECOR1 CAPITAL, LLC is the largest shareholder of the company, while 236.0 institutions own stock in it. As of 2024-06-30, the company held over 11.58 million shares (or 21.5666% of all shares), a total value of $239.1 million in shares.
The next largest institutional holding, with 8.07 million shares, is of FMR LLC’s that is approximately 15.016% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $166.48 million.
